Exploring the use of intracellular and extracellular allosteric modulators to understand GPCR signaling

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Allosteric Modulation of G Protein-Coupled Receptors

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/b978-0-12-819771-4.00008-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands

  2021cited by this paper
• Combinatorial expression of GPCR isoforms affects signalling and drug responses

  2020cited by this paper
• Targeting of G-protein coupled receptors in sepsis.

  2020cited by this paper
• Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.

  2020cited by this paper
• Nanobody-enabled monitoring of kappa opioid receptor states

  2020cited by this paper
• Nanobodies to study protein conformational states.

  2020cited by this paper
• Structure-guided discovery of a single-domain antibody agonist against human apelin receptor

  2020cited by this paper
• Inhaled nanobodies against COVID-19

  2020cited by this paper
• A guide to: generation and design of nanobodies

  2020cited by this paper
• Synthetic nanobodies as angiotensin receptor blockers

  2020cited by this paper
• Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)

  2020cited by this paper
• The PAR4-derived pepducin P4Pal10 lacks effect on neutrophil GPCRs that couple to Gαq for signaling but distinctly modulates function of the Gαi-coupled coupled FPR2 and FFAR2.

  2020cited by this paper
• Modular transient nanoclustering of activated β2-adrenergic receptors revealed by single-molecule tracking of conformation-specific nanobodies

  2020cited by this paper
• Structural insights into emergent signaling modes of G protein–coupled receptors

  2020cited by this paper
• Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor

  2020cited by this paper
• Arresting Developments in Biased Signaling.

  2020cited by this paper
• Improved GPCR ligands from nanobody tethering

  2020cited by this paper
• Generation of synthetic nanobodies against delicate proteins

  2020cited by this paper
• An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike

  2020cited by this paper
• Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists

  2020cited by this paper
• A nanobody-based fluorescent reporter reveals human α-synuclein in the cell cytosol

  2019cited by this paper
• Optogenetic control of protein binding using light-switchable nanobodies

  2019cited by this paper
• Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor.

  2019cited by this paper
• Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells

  2019cited by this paper
• Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities

  2019cited by this paper
• Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

  2019cited by this paper
• Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.

  2019cited by this paper
• Harnessing Ion-Binding Sites for GPCR Pharmacology

  2019cited by this paper
• A genetically encoded biosensor reveals location bias of opioid drug action

  2018cited by this paper
• Yeast surface display platform for rapid discovery of conformationally selective nanobodies

  2018cited by this paper
• Nanobody-Enabled Reverse Pharmacology on G-Protein-Coupled Receptors.

  2018cited by this paper
• Receptor- and cellular compartment-specific activation of the cAMP/PKA pathway by α1-adrenergic and ETA endothelin receptors.

  2018cited by this paper
• Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor

  2018cited by this paper
• Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.

  2018cited by this paper
• Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor

  2018cited by this paper
• A versatile nanobody-based toolkit to analyze retrograde transport from the cell surface

  2018cited by this paper
• The Molecular Basis of G Protein-Coupled Receptor Activation.

  2018cited by this paper
• Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor

  2018cited by this paper
• SNAP-tagged nanobodies enable reversible optical control of a G protein-coupled receptor via a remotely tethered photoswitchable ligand

  2018cited by this paper
• Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors.

  2018cited by this paper
• Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling

  2018cited by this paper
• Structural insights into binding specificity, efficacy and bias of a β2AR partial agonist

  2018cited by this paper
• Genetically Encoded Fluorescent Biosensors Illuminate the Spatiotemporal Regulation of Signaling Networks.

  2018cited by this paper
• Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR Signaling.

  2018cited by this paper
• Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

  2018cited by this paper
• GPCR Dynamics: Structures in Motion.

  2017cited by this paper
• Functional selectivity of GPCR-directed drug action through location bias

  2017cited by this paper
• Escherichia coli surface display for the selection of nanobodies

  2017cited by this paper
• Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation

  2017cited by this paper
• Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

  2017cited by this paper
• Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein–Protein Interaction Analysis, and Protein Function Exploration

  2017cited by this paper
• Synthetic single domain antibodies for the conformational trapping of membrane proteins

  2017cited by this paper
• Single-molecule imaging reveals receptor–G protein interactions at cell surface hot spots

  2017cited by this paper
• Targeting Liver Fibrosis with a Cell-penetrating Protease-activated Receptor-2 (PAR2) Pepducin*

  2016cited by this paper
• Allosteric Nanobodies Reveal the Dynamic Range and Diverse Mechanisms of GPCR Activation

  2016cited by this paper
• Allosteric coupling from G protein to the agonist binding pocket in GPCRs

  2016cited by this paper
• Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

  2016cited by this paper
• β-arrestin–biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction

  2016cited by this paper
• From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins.

  2016cited by this paper
• Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms

  2016cited by this paper
• Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics*

  2015cited by this paper
• Fourth-Generation Epac-Based FRET Sensors for cAMP Feature Exceptional Brightness, Photostability and Dynamic Range: Characterization of Dedicated Sensors for FLIM, for Ratiometry and with High Affinity

  2015cited by this paper
• Structural insights into μ-opioid receptor activation

  2015cited by this paper
• Endogenous Allosteric Modulators of G Protein–Coupled Receptors

  2015cited by this paper
• Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.

  2015cited by this paper
• Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase

  2014cited by this paper
• Allosteric sodium in class A GPCR signaling.

  2014cited by this paper
• Structural features of the G-protein/GPCR interactions.

  2014cited by this paper
• Development and Characterization of Pepducins as Gs-biased Allosteric Agonists*♦

  2014cited by this paper
• A general protocol for the generation of Nanobodies for structural biology

  2014cited by this paper
• Genetically encoded Ca(2+) indicators: properties and evaluation.

  2013cited by this paper
• Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein

  2013cited by this paper
• FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes.

  2013cited by this paper
• Activation and allosteric modulation of a muscarinic acetylcholine receptor

  2013cited by this paper
• Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor

  2013cited by this paper
• Adrenaline-activated structure of the β2-adrenoceptor stabilized by an engineered nanobody

  2013cited by this paper
• Regulation of Beta-2-Adrenergic Receptor Function by Conformationally Selective Single-domain Intrabodies

  2013cited by this paper
• Nanobodies: natural single-domain antibodies.

  2013cited by this paper
• Conformational biosensors reveal GPCR signalling from endosomes

  2013cited by this paper
• N-Terminal T4 Lysozyme Fusion Facilitates Crystallization of a G Protein Coupled Receptor

  2012cited by this paper
• Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol

  2012cited by this paper
• Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions

  2012cited by this paper
• Fusion partner toolchest for the stabilization and crystallization of G protein-coupled receptors.

  2012cited by this paper
• Biased signalling and allosteric machines: new vistas and challenges for drug discovery

  2012cited by this paper
• Functional Selectivity and Biased Receptor Signaling

  2011cited by this paper
• Nanobody stabilization of G protein-coupled receptor conformational states.

  2011cited by this paper
• Targeting the prostaglandin F2α receptor for preventing preterm labor with azapeptide tocolytics.

  2011cited by this paper
• Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

  2011cited by this paper
• G protein–coupled receptor modulation with pepducins: moving closer to the clinic

  2011cited by this paper
• Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor

  2011cited by this paper
• Development of an optimized backbone of FRET biosensors for kinases and GTPases

  2011cited by this paper
• Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models.

  2011cited by this paper
• Structure of a nanobody-stabilized active state of the β2 adrenoceptor

  2010cited by this paper
• Energy landscapes as a tool to integrate GPCR structure, dynamics, and function.

  2010cited by this paper
• A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway*

  2010cited by this paper
• Functional Selectivity of Natural and Synthetic Prostaglandin EP4 Receptor Ligands

  2009cited by this paper
• Heterotrimeric G protein activation by G-protein-coupled receptors

  2008cited by this paper
• High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor

  2007cited by this paper
• Role of the prostaglandins in labour and prostaglandin receptor inhibitors in the prevention of preterm labour.

  2007cited by this paper
• Crystal structure of the human β2 adrenergic G-protein-coupled receptor

  2007cited by this paper

• Deep learning reveals endogenous sterols as allosteric modulators of the GPCR–Gα interface

  2025cites this paper